BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18794110)

  • 1. A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.
    Winner M; Meier J; Zierow S; Rendon BE; Crichlow GV; Riggs R; Bucala R; Leng L; Smith N; Lolis E; Trent JO; Mitchell RA
    Cancer Res; 2008 Sep; 68(18):7253-7. PubMed ID: 18794110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
    Mawhinney L; Armstrong ME; O' Reilly C; Bucala R; Leng L; Fingerle-Rowson G; Fayne D; Keane MP; Tynan A; Maher L; Cooke G; Lloyd D; Conroy H; Donnelly SC
    Mol Med; 2015 Apr; 20(1):729-35. PubMed ID: 25826675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis.
    Zheng L; Feng Z; Tao S; Gao J; Lin Y; Wei X; Zheng B; Huang B; Zheng Z; Zhang X; Liu J; Shan Z; Chen Y; Chen J; Zhao F
    Clin Transl Med; 2022 Jan; 12(1):e652. PubMed ID: 35060345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
    Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
    J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
    Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T
    Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.
    Rajasekaran D; Zierow S; Syed M; Bucala R; Bhandari V; Lolis EJ
    FASEB J; 2014 Nov; 28(11):4961-71. PubMed ID: 25016026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
    Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
    Garai J; Lóránd T
    Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
    Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
    FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
    Safi W; Kraus A; Grampp S; Schödel J; Buchholz B
    J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Plasticity in the C-Terminal Region of Macrophage Migration Inhibitory Factor-2 Is Associated with an Induced Fit Mechanism for a Selective Inhibitor.
    Pantouris G; Bucala R; Lolis EJ
    Biochemistry; 2018 Jul; 57(26):3599-3605. PubMed ID: 29847104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
    Cheng KF; Al-Abed Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness.
    Jovanović Krivokuća M; Stefanoska I; Abu Rabi T; Al-Abed Y; Stošić-Grujičić S; Vićovac Lj
    Placenta; 2015 Feb; 36(2):150-9. PubMed ID: 25530499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
    Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
    Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
    Barbosa de Souza Rizzo M; Brasilino de Carvalho M; Kim EJ; Rendon BE; Noe JT; Darlene Wise A; Mitchell RA
    QJM; 2018 Nov; 111(11):769-778. PubMed ID: 30016493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
    Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
    Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
    Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
    J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).
    Bai F; Asojo OA; Cirillo P; Ciustea M; Ledizet M; Aristoff PA; Leng L; Koski RA; Powell TJ; Bucala R; Anthony KG
    J Biol Chem; 2012 Aug; 287(36):30653-63. PubMed ID: 22782901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF family members cooperatively inhibit p53 expression and activity.
    Brock SE; Rendon BE; Xin D; Yaddanapudi K; Mitchell RA
    PLoS One; 2014; 9(6):e99795. PubMed ID: 24932684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
    Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
    Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.